stockportfolio.pro
Stocks / GILD vs ISRG
GILD vs ISRG
Gilead Sciences, Inc. and Intuitive Surgical, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Gilead Sciences, Inc. (GILD) | Intuitive Surgical, Inc. (ISRG) | |
|---|---|---|
| Market cap | $155.8B | $151.1B |
| Revenue (latest FY) | $29.44B | $10.06B |
| Net income (latest FY) | $8.51B | $2.86B |
| Revenue growth (5y CAGR) | 3.6% | 18.2% |
| Net margin | 28.9% | 28.4% |
| Return on equity | 37.5% | 16.0% |
| P/E ratio | 17.1 | 51.7 |
| Dividend yield | 2.6% | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open GILD — free Open ISRG — freeFrequently asked questions
Which is bigger, GILD or ISRG?
Gilead Sciences, Inc. is larger by market capitalization — $155.8B versus $151.1B.
Which grows faster, GILD or ISRG?
Over the last five fiscal years, Intuitive Surgical, Inc. grew revenue faster — 18.2%/yr versus 3.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.